1. Advantages of Chemical Redox Agents 878 2. Disadvantages of Chemical Redox Agents 879 C. Potentials in Nonaqueous Solvents 879 D. Reversible vs Irreversible ET Reagents 879 E. Categorization of Reagent Strength 881 II. Oxidants 881 A. Inorganic 881 1. Metal and Metal Complex Oxidants 881 2. Main Group Oxidants 887 B. Organic 891 1. Radical Cations 891 2. Carbocations 893 3. Cyanocarbons and Related Electron-Rich Compounds 894

/pdf/chemical-redox-agents-for-organometallic-chemistry-4fs84ntwp8.pdf

Chemical Redox Agents for Organometallic Chemistry

Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids

2.1.4. Effect of Bases and Other Additives 4628 2.1.5. Improved Catalytic Systems 4629 2.1.6. Applications in Synthesis 4630 2.1.7. Mechanistic Studies 4632 2.1.8. Related Matsuda−Heck Reactions 4633 2.2. Suzuki−Miyaura Reaction 4634 2.2.1. Early Studies 4634 2.2.2. Modification of the Boronic Counterpart 4635 2.2.3. Improved Catalytic Systems 4637 2.2.4. Superior Reactivity of N2 as the Nucleofuge 4637

/pdf/diazonium-salts-as-substrates-in-palladium-catalyzed-cross-4v8qzijgi3.pdf

Diazonium salts as substrates in palladium-catalyzed cross-coupling reactions.

Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one Raf protein kinase. In certain aspects and embodiments, the described compounds are active in inhibiting proliferation of a Ras mutant cell line. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of B-Raf V600E mutant protein kinase, including melanoma, glioma, glioblastoma multiforme, pilocytic astrocytoma, colorectal cancer, thyroid cancer, lung cancer, ovarian cancer, prostate cancer, liver cancer, gallbladder cancer, gastrointestinal stromal tumors, biliary tract cancer, and cholangiocarcinoma. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of c-Raf-1 protein kinase, including acute pain, chronic pain or polycystic kidney disease.

Compounds and methods for kinase modulation, and indications therefor

Potassium Trifluoro(organo)borates: New Perspectives in Organic Chemistry

Alkyl nitrite-metal halide deamination reactions. 6. Direct synthesis of arenediazonium tetrafluoroborate salts from aromatic amines, tert-butyl nitrite, and boron trifluoride etherate in anhydrous media

William J. Bryker

Papers

Alkyl nitrite-metal halide deamination reactions. 6. Direct synthesis of arenediazonium tetrafluoroborate salts from aromatic amines, tert-butyl nitrite, and boron trifluoride etherate in anhydrous media